Bradley Holt, MD
Interventional Pain Medicine · Tucson, AZNPI 1922230507
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Boston Scientific at 36.8% of the total. Reporting peaked in 2022 at $4,486 and has fallen 69.2% since, to $1,384 in 2025.
Across 242 payments — averaging $63.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Medtronic$5K
- Abbott$3K
- Nevro Corp.$338
- SPR Therapeutics, Inc$201
- Stimwave Technologies Incorporated$165
- plus $195 from 4 others
Across 31 payments — averaging $15,896 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$493K
What the payments were for
- Travel & lodging$6,76444%
- Food & beverage$8,56856%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 110 | $5,643 |
| Medtronic(2 entities) | 71 | $5,362 |
| Abbott | 40 | $3,430 |
| Nevro Corp. | 4 | $338 |
| SPR Therapeutics, Inc | 3 | $201 |
| Stimwave Technologies Incorporated | 7 | $165 |
| Nalu Medical, Inc. | 4 | $117 |
| Glaukos Corporation | 1 | $49 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,826
- INTELLIS ADAPTIVESTIM$1,772
- Proclaim Family of SCS IPGs$1,231
- PROCLAIM$990
- KYPHON EXPRESS II KYPHOPAK TRAY$780
- SPECTRA WAVEWRITER$743
- RESTORE$739
- Proclaim IPG$360
- Senza$313
- INCEPTIV$296
- WAVEWRITER ALPHA$287
- Intracept$269
- ARTISAN$241
- INTELLIS$176
- KYPHON Balloon Kyphoplasty$142
How this compares
$15,333 in reported general payments places this provider in the 65th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 272 | $3,169 |
| Celecoxib | 31 | $337 |
| Duloxetine Hcl | 26 | $302 |
| Tramadol Hcl | 82 | $297 |
| Methylprednisolone | 37 | $274 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $191 |
| Tizanidine Hcl | 35 | $141 |
| Pregabalin | 18 | $125 |
| Meloxicam | 36 | $86 |
| Diazepam | 57 | $70 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $62 |
| Amitriptyline Hcl | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Tucson
- Kyung ChenTucson$16K
- Stephen ShillerTucson$3K
- Iftequar SiddiquiTucson$2K
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.